Vectibix

In the US, Vectibix (panitumumab systemic) is a member of the drug class EGFR inhibitors and is used to treat Colorectal Cancer.

US matches:

• Vectibix

UK matches:

• Vectibix
• Vectibix (SPC)

Ingredient matches for Vectibix

Panitumumab

Panitumumab is reported as an ingredient of Vectibix in the following countries:

• Australia


• Austria


• Belgium


• Canada


• Denmark


• Germany


• Ireland


• Luxembourg


• Netherlands


• Norway


• Slovakia


• Slovenia


• Spain


• Sweden


• Switzerland


• United Kingdom


• United States

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Simvastatin Krewel

Simvastatin Krewel may be available in the countries listed below.

Ingredient matches for Simvastatin Krewel

Simvastatin

Simvastatin is reported as an ingredient of Simvastatin Krewel in the following countries:

• Germany

International Drug Name Search

Propranolol Ratiopharm

Propranolol Ratiopharm may be available in the countries listed below.

Ingredient matches for Propranolol Ratiopharm

Propranolol

Propranolol hydrochloride (a derivative of Propranolol) is reported as an ingredient of Propranolol Ratiopharm in the following countries:

• France

International Drug Name Search

Zuplenz

Zuplenz is a brand name of ondansetron, approved by the FDA in the following formulation(s):

ZUPLENZ (ondansetron - film; oral)

• 
  Manufacturer: MONOSOL RX LLC
  
  Approval date: July 2, 2010
  
  Strength(s): 4MG, 8MG ^[RLD]

Has a generic version of Zuplenz been approved?

No. There is currently no therapeutically equivalent version of Zuplenz available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Zuplenz. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Zuplenz.

See also...

• Zuplenz Consumer Information (Drugs.com)
• Zuplenz Soluble Film Consumer Information (Wolters Kluwer)
• Zuplenz Consumer Information (Cerner Multum)
• Zuplenz Advanced Consumer Information (Micromedex)
• Ondansetron Consumer Information (Drugs.com)
• Ondansetron Consumer Information (Wolters Kluwer)
• Ondansetron Orally Disintegrating Tablets Consumer Information (Wolters Kluwer)
• Ondansetron Soluble Film Consumer Information (Wolters Kluwer)
• Ondansetron Solution Consumer Information (Wolters Kluwer)
• Ondansetron Tablets Consumer Information (Wolters Kluwer)
• Ondansetron Consumer Information (Cerner Multum)
• Ondansetron injection Consumer Information (Cerner Multum)
• Ondansetron Oral, Injection, Intravenous Advanced Consumer Information (Micromedex)
• Ondansetron Oral, Oromucosal Advanced Consumer Information (Micromedex)
• Ondansetron Hydrochloride AHFS DI Monographs (ASHP)

Doclinisopril

Doclinisopril may be available in the countries listed below.

Ingredient matches for Doclinisopril

Lisinopril

Lisinopril is reported as an ingredient of Doclinisopril in the following countries:

• Luxembourg

International Drug Name Search

Spar

Spar may be available in the countries listed below.

Ingredient matches for Spar

Sparfloxacin

Sparfloxacin is reported as an ingredient of Spar in the following countries:

• Bangladesh

International Drug Name Search

Sex-Men

Sex-Men may be available in the countries listed below.

Ingredient matches for Sex-Men

Sildenafil

Sildenafil citrate (a derivative of Sildenafil) is reported as an ingredient of Sex-Men in the following countries:

• Colombia

International Drug Name Search